LGVN

LGVN

USD

Longeveron Inc. Class A Common Stock

$0.800-0.020 (-2.439%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$0.820

最高价

$0.820

最低价

$0.800

成交量

0.38M

公司基本面

市值

16.8M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.95M

交易所

NCM

货币

USD

52周价格范围

最低价 $0.633当前价 $0.800最高价 $2.31

相关新闻

GlobeNewswire

Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025

MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions,

查看更多
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
GlobeNewswire

Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect

Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHSFull enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II)

查看更多
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect